Health Resources and Services Administration (HRSA) released the procedures and requirements for the 340B Program’s Administrative Dispute Resolution (“ADR”). This has been 10 years in
Hospitals Sue HHS over Pharma 340B Pricing for contract Pharmacy attack.See complaint attached.
US House letter to HHS regarding Kalderos and their new program called “340B Pay”. 340B Pay will uproot the current 340B cash flow model and
Health Centers Sue HHS over Pharma 340B Pricing for Contract Pharmacy attack.See complaint attached.
AstraZeneca and Sanofi Block Access to 340B Contract Pharmacy Pricing but not Novartis. See the letter from Sanofi attached.
HHS letter to Eli Lilly in response to their 340B price restrictions. HHS Tells Lilly, Don’t assume we agree on your position about 340B. See
U.S. senators wrote to the U.S. Health and Human Services (HHS) to urge the U.S. Health Resources and Services Administration (HRSA) “to take immediate action
Lilly starts the trend to limit 340B pricing to contract pharmacies. Other drug manufacturers follow including Sanofi, Merck, AstraZeneca, United Therapeutics, Novartis, Novo Nordisk See
